These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3418493)

  • 1. Non-linear hepatic first-pass metabolism of salicylamide in dogs after portacaval transposition.
    Pond SM; Mahachai V; Effeney DJ; Tozer TN
    J Pharmacokinet Biopharm; 1988 Apr; 16(2):161-4. PubMed ID: 3418493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
    Pond SM; Waschek JA; Mahacha V; Fielding RM; Effeney DJ; Tozer TN
    J Pharmacol Exp Ther; 1988 Apr; 245(1):291-3. PubMed ID: 3361447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent determination of hepatic bioavailability of salicylamide by three techniques in the dog.
    Tozer TN; Callaway J; Hellgeth M; Mahachai V; Effeney DJ; Pond SM
    J Pharm Sci; 1989 Jun; 78(6):462-4. PubMed ID: 2760819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.
    Gugler R; Lain P; Azarnoff DL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):416-23. PubMed ID: 1195128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent, plasma-sulfate-independent kinetics of salicylamide in dogs.
    Waschek JA; Fielding RM; Tozer TN; Effeney DJ; Pond SM
    J Pharmacokinet Biopharm; 1988 Apr; 16(2):151-9. PubMed ID: 3418492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions.
    Lo MW; Pond SM; Effeney DJ; Silber BM; Riegelman S; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):401-12. PubMed ID: 6527232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-pass metabolism of salicylamide. Studies in the once-through vascularly perfused rat intestine-liver preparation.
    Xu X; Hirayama H; Pang KS
    Drug Metab Dispos; 1989; 17(5):556-63. PubMed ID: 2573500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
    Pang KS; Barker F; Schwab AJ; Goresky CA
    J Pharmacol Exp Ther; 1994 Jul; 270(1):285-95. PubMed ID: 8035326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
    Waschek JA; Rubin GM; Tozer TN; Fielding RM; Couet WR; Effeney DJ; Pond SM
    J Pharmacol Exp Ther; 1984 Jul; 230(1):89-93. PubMed ID: 6747835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salicylamide sulfate cell entry in perfused rat liver: a multiple-indicator dilution study.
    Xu X; Schwab AJ; Barker F; Goresky CA; Pang KS
    Hepatology; 1994 Jan; 19(1):229-44. PubMed ID: 8276359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition.
    Lo MW; Effeney DJ; Pond SM; Silber BM; Riegelman S
    J Pharmacol Exp Ther; 1982 May; 221(2):512-5. PubMed ID: 7077541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of the capacity of the liver to remove ammonia from the circulation of dogs with portacaval transposition.
    Aldrete JS
    Surg Gynecol Obstet; 1975 Sep; 141(3):399-404. PubMed ID: 1162568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A technique to study hepatic and intestinal drug metabolism separately in the dog.
    Effeney DJ; Pond SM; Lo MW; Silber BM; Riegelman S
    J Pharmacol Exp Ther; 1982 May; 221(2):507-11. PubMed ID: 7077540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo.
    Rossaro L; Mazzaferro V; Scotti-Foglieni CL; Williams DS; Simplaceanu E; Simplaceanu V; Francavilla A; Starzl TE; Ho C; Van Thiel DH
    Hepatology; 1991 Apr; 13(4):780-5. PubMed ID: 2010174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of portacaval transposition on hepatic cytochrome P-450 in the rat.
    Pector JC; Ossenberg FW; Peignoux M; Benhamou JP
    Biomedicine; 1975 Jun; 23(5):160-2. PubMed ID: 1191728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of aspirin and salicylamide following oral co-administration in human volunteers.
    Abdel-Rahman MS; Reddi AS; Curro FA; Turkall RM; Kadry AM; Hansrote JA
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1436-42. PubMed ID: 1777842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary beneficial effect of arterialization of the liver in cirrhotic dogs with a portacaval shunt. A preliminary report.
    Terpstra OT; van Vroonhoven TJ; Noordhoek J; ten Kate FJ; Wilson JH
    Eur Surg Res; 1982; 14(5):333-43. PubMed ID: 7128651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of portacaval shunt, transposition, and dimethylnitrosamine-induced chronic liver injury on pancreatic hormones and amino acids in dog.
    Hashimoto N; Ishikawa Y; Utsunomiya J
    J Surg Res; 1989 Jan; 46(1):35-40. PubMed ID: 2644488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrahepatic extraction of salicylamide in dogs.
    Fielding RM; Waschek JA; Effeney DJ; Pogany AC; Pond SM; Tozer TN
    J Pharmacol Exp Ther; 1986 Jan; 236(1):97-102. PubMed ID: 3941404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of route of administration on competitive drug biotransformation interaction: salicylamide-ascorbic acid interaction in rats.
    Houston JB; Levy G
    J Pharmacol Exp Ther; 1976 Aug; 198(2):284-94. PubMed ID: 948026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.